Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Seagen Inc.
Seagen Inc.
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Astellas Pharma Inc
Tomsk National Research Medical Center of the Russian Academy of Sciences
Institute of Cancer Research, United Kingdom
M.D. Anderson Cancer Center
Hoffmann-La Roche
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
University of California, Davis
Arcus Biosciences, Inc.
Erasca, Inc.
Arcus Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Duke University
Cedars-Sinai Medical Center
AstraZeneca
Washington University School of Medicine
Alliance for Clinical Trials in Oncology
Poseida Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
National Health Research Institutes, Taiwan
IRCCS San Raffaele
Memorial Sloan Kettering Cancer Center
Nuvation Bio Inc.
TORL Biotherapeutics, LLC
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Queen Mary University of London
University of Arizona
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
Cedars-Sinai Medical Center
Taiho Oncology, Inc.
Suzhou Transcenta Therapeutics Co., Ltd.
University of Nebraska
ImmunityBio, Inc.
Legend Biotech USA Inc